Domov › Atopická dermatitída (ekzém) › South Carolina
Klinické štúdie Atopická dermatitída (ekzém) v štáte South Carolina
10 štúdií pre Atopická dermatitída (ekzém) hľadá účastníkov v zariadeniach v štáte South Carolina.
Mestá v štáte South Carolina
Oficiálny text štúdie (anglicky)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Advanced Dermatology and Cosmetic Surgery - Spartanburg- Site Number : 8400004, Spartanburg
Prebieha náborObservačná štúdia
Vek 12 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07290803A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Medical University of South Carolina - South Carolina Translational Research Nexus Clinic, Charleston
- Tribe Clinical Research, LLC, Greenville
Prebieha náborFáza 3
Vek 2 až 11 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06807281First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- National Allergy and Asthma Research, LLC, North Charleston
Prebieha náborFáza 1Vítaní zdravých dobrovoľníkov
Vek 18 až 65 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07527923A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Charleston
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07003425A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 12, Anderson
Prebieha náborFáza 2
Vek 18 až 74 · Všetky pohlavia · Aktualizované 12. 8. 2026 · NCT07037901A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Medical University of South Carolina /ID# 265113, Charleston
Prebieha náborFáza 3
Vek 2 až 11 · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT06461897A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Charleston
Prebieha náborFáza 3
6 Months – 11 Years · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Medical University of South Carolina /ID# 263655, Charleston
- Advanced Dermatology And Cosmetic Surgery - Spartanburg /ID# 267185, Spartanburg
Prebieha náborFáza 3
Vek 18 až 63 · Všetky pohlavia · Aktualizované 6. 7. 2026 · NCT06389136A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- National Allergy and Asthma, North Charleston
- Spartanburg Medical Research, Spartanburg
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 5. 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7106, Bluffton
Prebieha náborObservačná štúdia
Vek 12 a viac · Všetky pohlavia · Aktualizované 13. 3. 2026 · NCT06988605Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.